The 2027 CARRA-Arthritis Foundation Large Grant supports established investigators conducting innovative pediatric rheumatology research to benefit children with rheumatic diseases and improve outcomes.
Funder: Childhood Arthritis and Rheumatology Research Alliance
Due Dates: December 11, 2026 (Letter of Intent) | March 15, 2027 (Full application)
Funding Amounts: $250,000 per award over two years
Summary: Supports established investigators pursuing innovative pediatric rheumatology research that benefits children with rheumatic diseases.
Key Information: The principal investigator must be a current CARRA member with an advanced degree and a faculty or equivalent government appointment.
The Childhood Arthritis and Rheumatology Research Alliance (CARRA) offers this grant to help established investigators initiate, advance, or expand innovative basic, clinical, or translational research in pediatric rheumatology. Projects must align with CARRA’s mission, 2026–2028 Strategic Plan, and Research Agenda.
CARRA’s peer-reviewed grant program reflects its emphasis on collaboration among academicians, clinicians, patients, and families. Applicants must explain how their work will directly or indirectly benefit patients and improve outcomes for children with rheumatic diseases.